![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 30, 28484-28492, July 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Hydroxysteroid
Dehydrogenase Type 2*
,
From the Department of Clinical Research, Division of Nephrology
and Hypertension, University of Berne, 3010 Berne, Switzerland
11
-Hydroxysteroid dehydrogenase
(11
-HSD) type 2 has been considered to protect the mineralocorticoid
receptor (MR) by converting 11
-hydroxyglucocorticoids into their
inactive 11-keto forms, thereby providing specificity to the MR for
aldosterone. To investigate the functional protection of the MR by
11
-HSD2, we coexpressed epitope-tagged MR and 11
-HSD2 in HEK-293
cells lacking 11
-HSD2 activity and analyzed their subcellular
localization by fluorescence microscopy. When expressed alone in the
absence of hormones, the MR was both cytoplasmic and nuclear. However,
when coexpressed with 11
-HSD2, the MR displayed a reticular
distribution pattern, suggesting association with 11
-HSD2 at the
endoplasmic reticulum membrane. The endoplasmic reticulum membrane
localization of the MR was observed upon coexpression only with
11
-HSD2, but not with 11
-HSD1 or other steroid-metabolizing
enzymes. Aldosterone induced rapid nuclear translocation of the MR,
whereas moderate cortisol concentrations (10-200 nM)
did not activate the receptor, due to 11
-HSD2-dependent
oxidation to cortisone. Compromised 11
-HSD2 activity (due to genetic
mutations, the presence of inhibitors, or saturating cortisol
concentrations) led to cortisol-induced nuclear accumulation of the MR.
Surprisingly, the 11
-HSD2 product cortisone blocked the
aldosterone-induced MR activation by a strictly 11
-HSD2-dependent mechanism. Our results provide
evidence that 11
-HSD2, besides inactivating
11
-hydroxyglucocorticoids, functionally interacts with the MR and
directly regulates the magnitude of aldosterone-induced MR activation.
To whom correspondence should be addressed: Dept. of Clinical
Research, Div. of Nephrology and Hypertension, University of Berne,
Freiburgstr. 15, 3010 Berne, Switzerland. Tel.: 41-31-632-9438; Fax:
41-31-632-9444; E-mail: alex.odermatt@dkf2.unibe.ch.
This article has been cited by other articles:
![]() |
Y. Liu, F. Park, J. L. Pietrusz, G. Jia, R. J. Singh, B. C. Netzel, and M. Liang Suppression of 11{beta}-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis Physiol Genomics, February 19, 2008; 32(3): 343 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Atanasov, I. D. Ignatova, L. G. Nashev, B. Dick, P. Ferrari, F. J. Frey, and A. Odermatt Impaired Protein Stability of 11beta-Hydroxysteroid Dehydrogenase Type 2: A Novel Mechanism of Apparent Mineralocorticoid Excess J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1262 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Geerling, W. C. Engeland, M. Kawata, and A. D. Loewy Aldosterone Target Neurons in the Nucleus Tractus Solitarius Drive Sodium Appetite J. Neurosci., January 11, 2006; 26(2): 411 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Fuller and M. J. Young Mechanisms of Mineralocorticoid Action Hypertension, December 1, 2005; 46(6): 1227 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Koch, A. Schuffenhauer, M. Scheck, S. Wetzel, M. Casaulta, A. Odermatt, P. Ertl, and H. Waldmann Charting biologically relevant chemical space: A structural classification of natural products (SCONP) PNAS, November 29, 2005; 102(48): 17272 - 17277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Paterson, J. R. Seckl, and J. J. Mullins Genetic manipulation of 11{beta}-hydroxysteroid dehydrogenases in mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R642 - R652. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Walther, E. Atlas, A. Carrigan, Y. Rouleau, A. Edgecombe, L. Visentin, C. Lamprecht, G. C. Addicks, R. J. G. Hache, and Y. A. Lefebvre A Serine/Threonine-rich Motif Is One of Three Nuclear Localization Signals That Determine Unidirectional Transport of the Mineralocorticoid Receptor to the Nucleus J. Biol. Chem., April 29, 2005; 280(17): 17549 - 17561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Frick, A. G. Atanasov, P. Arnold, J. Ozols, and A. Odermatt Appropriate Function of 11{beta}-Hydroxysteroid Dehydrogenase Type 1 in the Endoplasmic Reticulum Lumen Is Dependent on Its N-terminal Region Sharing Similar Topological Determinants with 50-kDa Esterase J. Biol. Chem., July 23, 2004; 279(30): 31131 - 31138. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Madsen, J. Stubbe, T. Yang, O. Skott, S. Bachmann, and B. L. Jensen Low endogenous glucocorticoid allows induction of kidney cortical cyclooxygenase-2 during postnatal rat development Am J Physiol Renal Physiol, January 1, 2004; 286(1): F26 - F37. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ouvrard-Pascaud, S. Puttini, Y. Sainte-Marie, R. Athman, V. Fontaine, F. Cluzeaud, N. Farman, M.-E. Rafestin-Oblin, M. Blot-Chabaud, and F. Jaisser Conditional gene expression in renal collecting duct epithelial cells: use of the inducible Cre-lox system Am J Physiol Renal Physiol, January 1, 2004; 286(1): F180 - F187. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Norregaard, T. R. Uhrenholt, C. Bistrup, O. Skott, and B. L. Jensen Stimulation of 11-{beta}-hydroxysteroid dehydrogenase type 2 in rat colon but not in kidney by low dietary NaCl intake Am J Physiol Renal Physiol, August 1, 2003; 285(2): F348 - F358. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Kalman and R. L. Spencer Rapid Corticosteroid-Dependent Regulation of Mineralocorticoid Receptor Protein Expression in Rat Brain Endocrinology, November 1, 2002; 143(11): 4184 - 4195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prufer and J. Barsony Retinoid X Receptor Dominates the Nuclear Import and Export of the Unliganded Vitamin D Receptor Mol. Endocrinol., August 1, 2002; 16(8): 1738 - 1751. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Stauffer, M. K. Rochat, B. Dick, F. J. Frey, and A. Odermatt Chenodeoxycholic Acid and Deoxycholic Acid Inhibit 11beta -Hydroxysteroid Dehydrogenase Type 2 and Cause Cortisol-induced Transcriptional Activation of the Mineralocorticoid Receptor J. Biol. Chem., July 12, 2002; 277(29): 26286 - 26292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Mohaupt and F. J. Frey Mineralocorticoid receptor malfunction: further insights from rare forms of hypertension Nephrol. Dial. Transplant., April 1, 2002; 17(4): 539 - 542. [Full Text] [PDF] |
||||
![]() |
A. Serra, D. E. Uehlinger, P. Ferrari, B. Dick, B. M. Frey, F. J. Frey, and B. Vogt Glycyrrhetinic Acid Decreases Plasma Potassium Concentrations in Patients with Anuria J. Am. Soc. Nephrol., January 1, 2002; 13(1): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Sheppard Nuclear Receptors: II. Intestinal corticosteroid receptors Am J Physiol Gastrointest Liver Physiol, May 1, 2002; 282(5): G742 - G746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |